Experimental injection offers new hope for Treatment-Resistant lupus patients
Disease control
Recruiting now
This early-stage study is testing a new injection called AFN50 for people with autoimmune diseases, focusing on lupus that has returned or hasn't responded to standard treatments. Researchers want to see if AFN50 is safe and if it can help control lupus symptoms by measuring dise…
Phase: EARLY_PHASE1 • Sponsor: AlphaNa Bioscience Company Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC